Design and characterization of a mucoadhesive nanoparticle-loaded thermo-responsive in-situ nasal gel for enhanced brain delivery of an antimigraine drug
DOI:
https://doi.org/10.69857/joapr.v14i3.2063Keywords:
Antimigraine, Blood-brain barrier, Central nervous system, Patient adherence, Nasal integrityAbstract
Background: Migraine is a debilitating neurological disorder that requires rapid and effective drug delivery to the brain. Conventional oral and parenteral therapies are associated with delayed onset of action, low patient compliance, limited central nervous system (CNS) bioavailability due to the blood-brain barrier (BBB), and hepatic first-pass metabolism. This study aimed to develop a thermoresponsive, mucoadhesive, nanoparticle-loaded nasal in situ gel to enhance brain delivery of an antimigraine drug. Methodology: Drug-loaded nanoparticles were prepared via ionic gelation and incorporated into a thermo-sensitive nasal in situ gel via the cold method. Results and Discussion: The optimized nanoparticle formulation (NP13) exhibited a small particle size (154.3 nm), acceptable polydispersity index (0.3485), positive zeta potential (22.79 mV), high entrapment efficiency (89.09%), drug loading (14.33%), and sustained drug release (90.26%). The developed in situ gel showed optimal pH (6.8), suitable gelling temperature (28–34 °C), viscosity (556 cp), entrapment efficiency (85%), drug content (95.82%), in vitro drug release (88.89 ± 0.98%), and ex vivo permeation (85.24 ± 0.67%) over 10 hours. Histopathological studies confirmed minimal nasal mucosal irritation compared to the drug solution and isopropyl alcohol. MTT assay results demonstrated concentration-dependent cytotoxicity, with SS-NPs ISG4 showing higher cell viability than the free drug, indicating reduced cytotoxicity due to nanoparticle encapsulation. Blank nanoparticles exhibited maximum cell survival, confirming carrier biocompatibility. Conclusion: The developed nanoparticle-loaded nasal in situ gel demonstrated promising safety, biocompatibility, and enhanced delivery potential, validating its suitability for intranasal migraine therapy.
Downloads
References
Torres J, Silva R, Farias G, Lobo JMS, Ferreira DC, Silva AC, et al. Enhancing acute migraine treatment: Exploring solid lipid nanoparticles and nanostructured lipid carriers for the nose-to-brain route. Pharmaceutics, 16, 1297 (2024) https://doi.org/10.3390/pharmaceutics16101297
Yadav RK, Shah K, Dewangan HK. Intranasal drug delivery of sumatriptan succinate-loaded polymeric solid lipid nanoparticles for brain targeting. Drug Dev. Ind. Pharm., 48, 21–28 (2022) https://doi.org/10.1080/03639045.2022.2090575
Nerella N, Vasudha B. Design, development, and optimization of sumatriptan loaded ethosomal intra-nasal nanogel for brain targeting. Journal of Applied Pharmaceutical Research, 12, 83–98 (2024) https://doi.org/10.69857/joapr.v12i4.610
Alshraim A, Alshora D, Ashri L, Alhusaini A, Alanazi N, Safwan NM. In situ thermosensitive mucoadhesive nasal gel containing sumatriptan: In vitro and ex vivo evaluations. Polymers (Basel), 16, 3422 (2024) https://doi.org/10.3390/polym16233422
Assadpour S, Shiran MR, Asadi P, Akhtari J, Sahebkar A. Harnessing intranasal delivery systems of sumatriptan for the treatment of migraine. Biomed Res. Int., 1–14 (2022) https://doi.org/10.1155/2022/xxxxxxx
Mathure D, Sutar AD, Ranpise H, Pawar A, Awasthi R. Preparation and optimization of liposome containing thermosensitive in situ nasal hydrogel system for brain delivery of sumatriptan succinate. Assay Drug Dev. Technol., 21, 3–16 (2023) https://doi.org/10.1089/adt.2022.088
Mathure D, Ranpise H, Awasthi R, Pawar A. Formulation and characterization of nanostructured lipid carriers of rizatriptan benzoate-loaded in situ nasal gel for brain targeting. Assay Drug Dev. Technol., 20, 211–224 (2022) https://doi.org/10.1089/adt.2022.044
Kalita R, Sarma A, Baruah H, Zaman A, Goswami D. Nose-to-brain delivery of curcumin loaded therapeutic nanostructures for neurodegenerative diseases. Biopharm. Drug Dispos. (2026) https://doi.org/10.1002/bdd.70021
Butola M, Nainwal N. Non-invasive techniques of nose to brain delivery using nanoparticulate carriers: Hopes and hurdles. AAPS PharmSciTech, 25, 256 (2024) https://doi.org/10.1208/s12249-024-02946-z
Barangule SP, Maru AD. Design and development of thermosensitive rectal in situ gel from Luffa acutangula fruits for the treatment of ulcerative colitis. Journal of Applied Pharmaceutical Research, 12, 102–115 (2024) https://doi.org/10.69857/joapr.v12i5.761
Mankar SD, Andhale A, Siddheshwar SS, Mhaske MP. Emodin-loaded mucoadhesive in situ nasal gel: Design, optimization, and evaluation for migraine therapy. BioNanoScience, 15, 412–421 (2025) https://doi.org/10.1007/s12668-025-02035-w
Dudhat K, Kachhadiya Y, Chotaliya M. Development of a thermosensitive in-situ nasal gel of teriflunomide for targeted CNS delivery in multiple sclerosis. J. Pharm. Innov., 21, 47–58 (2025) https://doi.org/10.1007/s12247-025-10291-2
Mujtaba MA, Rashid MA, Godbole MD, Alhamhoom Y, Shende DS, Alshehri S, et al. Escitalopram oxalate-loaded chitosan nanoparticle in situ gel intended for direct nose-to-brain delivery: In vitro, ex vivo, and in vivo pharmacokinetic evaluation. Front. Pharmacol., 16, 1577331 (2025) https://doi.org/10.3389/fphar.2025.157733
Rawat PS, Ravi PR, Mahajan RR. Design, pharmacokinetic, and pharmacodynamic evaluation of a lecithin-chitosan hybrid nanoparticle-loaded dual-responsive in situ gel of nebivolol for effective treatment of glaucoma. Discover Nano, 19, 156 (2024) https://doi.org/10.1186/s11671-024-04109-2
Hussain S, Malik N, Tulain U, Erum A, Mahmood A, Akram S, et al. Itraconazole-loaded polycaprolactone nanoparticle gel for enhanced transdermal delivery: Development, characterization, and ex vivo evaluation. Int. J. Nanomedicine, 20, 15655–15681 (2025) https://doi.org/10.2147/IJN.S56074
Bhute H, Salve PS, Sheikh S, Hussain UM, Tammewar S, Tatode AA, et al. Development of a gellan–Carbopol in situ gel system for intranasal delivery of artemether-loaded SLNs: Optimization and kinetic evaluation. J. Pharm. Innov., 21, 73–84 (2025) https://doi.org/10.1007/s12247-025-10263-6
Bajwa M, Tabassam N, Hameed H, Irfan A, Zaman M, Khan MA, et al. Thermo-responsive sol–gel-based nano-carriers containing terbinafine HCl: Formulation, in vitro and ex vivo characterization, and antifungal activity. Gels, 9, 830 (2023) https://doi.org/10.3390/gels9100830
Islam MM, Kumar M, Mujtaba MA, Elhassan GO, Abdoun S, Misbah M, et al. Formulation development, Box–Behnken design-based optimization and evaluation of cisplatin-loaded chitosan nanoparticles embedded in mucoadhesive buccal film for targeted oral cancer therapy. J. Pharm. Innov., 20, 276–289 (2025) https://doi.org/10.1007/s12247-025-10163-9
Longo E, Giuliano E, Gagliardi A, Gaetano V, Frisina M, Verdiglione M, et al. In situ forming poloxamer-based thermo-sensitive hydrogels for ocular application: A focus on the derivatives 407 and 188. Gels, 11, 752 (2025) https://doi.org/10.3390/gels11090752
Deshmane S, Chavan V, Nagpure S, Jain S, Solanki H, Sarode R, et al. Quality by design optimization of zolmitriptan nanostructured lipid carriers for nose-to-brain delivery in migraine. BioNanoScience, 16, 3–15 (2025) https://doi.org/10.1007/s12668-025-02278-7
Jha B, Majie A, Roy K, Lim WM, Gorain B. Glycyrrhizic acid-loaded poloxamer and HPMC-based in situ forming gel of acacia honey for improved wound dressing: Formulation optimization and characterization for wound treatment. ACS Appl. Bio Mater., 8, 310–328 (2024) https://doi.org/10.1021/acsabm.4c01212
Omidi M, Saeedi M, Zahiri MA, Azimi S, Mohammadian E, Hashemi SMH. Green arbutin–chitosan nanoparticles gel as an eco-friendly and promising product for skin lightening: In vitro and in vivo assessment. Nanomed. J., 13, 224–235 (2026) https://doi.org/10.22038/NMJ.2025.83053.2075
Wang Y, Han Z, Zhang C, Kang X, Jiang T, Li R, et al. Curcumin extraction and preparation and optimization of curcumin nanoparticles. Chin. J. Tissue Eng. Res., 30, 362–368 (2026) https://doi.org/10.12307/2025.497
Sarkar P, Desavathu M, Jain S, Mishra AK, Reddy RS, Sah PK. Mucoadhesive polymeric nanoparticles of fexofenadine hydrochloride for ocular delivery: Formulation, characterisation, and enhanced permeation studies. J. Pharm. Innov., 21, 65–77 (2025) https://doi.org/10.1007/s12247-025-10296-x
Suhagiya K, Borkhataria CH, Gohil S, Manek RA, Patel KA, Patel NK, et al. Development of mucoadhesive in situ nasal gel formulation for enhanced bioavailability and efficacy of rizatriptan in migraine treatment. Results Chem., 6, 101010 (2023) https://doi.org/10.1016/j.rechem.2023.101010
Mathure D, Ranpise H, Awasthi R, Pawar A. Formulation and characterization of nanostructured lipid carriers of rizatriptan benzoate-loaded in situ nasal gel for brain targeting. Assay Drug Dev. Technol., 20, 211–224 (2022) https://doi.org/10.1089/adt.2022.044
Adwan S, Obeidi T, Al-Akayleh F, et al. Chitosan nanoparticles embedded in in situ gel for nasal delivery of imipramine hydrochloride: Short-term stage development and controlled release evaluation. Polymers, 16, 3062 (2024) https://doi.org/10.3390/polym16213062
Patil VL, Rane BR, Mane NP, Jain AS. Preparation and optimization of beta-sitosterol nanosuspension-loaded in situ gel using Box–Behnken model for the treatment of prostate cancer. Micro Nanosyst., 17, 27–44 (2024) https://doi.org/10.2174/0118764029328588240816075844
Bilapatte A, More A, Satpute K, Syed SM. Formulation and evaluation of carbamazepine loaded ethosomal nasal in situ gel for brain targeted drug delivery. J. Holist. Integr. Pharm., 6, 57–63 (2025)
Rahbar N, Darvish S, Farrahi F, Kouchak M. Chitosan/carbomer nanoparticles-laden in situ gel for improved ocular delivery of timolol: In vitro, in vivo, and ex vivo study. Drug Deliv. Transl. Res., 15, 1210–1220 (2024) https://doi.org/10.1007/s13346-024-01663-1
Mandal S, Das NR, Mukherjee K, Giri TK. In vitro, ex vivo, and in vivo evaluation of polysaccharide-based thermo-sensitive in situ gel for the treatment of glaucoma. J. Biomater. Appl., 40, 650–665 (2026) https://doi.org/10.1177/08853282251369232
Rahmatpanahi A, Bavali A, Farhadi M, Bagheri-Khoulenjani S, Kaviani-Samani S. Illuminating RPMI-1640: Fluorescence dynamics and optical insights for biological applications. J. Photochem. Photobiol. A Chem., 469, 116537 (2025) https://doi.org/10.1016/j.jphotochem.2025.116537
Butola M, Nainwal N. In vivo, in vitro, and ex vivo experimental models for nose-to-brain drug delivery. Drug Deliv. Lett., 15 (2025) https://doi.org/10.2174/0122103031378584250829054818
Yadav R, Mani RJ, Sharma A, Kumar A, Katare D. Formulation and optimization of metformin-berberine loaded solid lipid nanoparticles for their neuroprotective effects in the brain. Journal of Applied Pharmaceutical Research, 13, 114–133 (2025) https://doi.org/10.69857/joapr.v13i5.1356
Steyn JD, Haasbroek-Pheiffer A, Pheiffer W, Weyers M, van Niekerk SE, Hamman JH, et al. Evaluation of drug permeation enhancement by using in vitro and ex vivo models. Pharmaceuticals, 18, 195 (2025) https://doi.org/10.3390/ph18020195
Das B, Umashankar MS. Design and optimization of a mucoadhesive gel containing solid lipid nanoparticles for sublingual and nasal delivery of a low bioavailable drug. Preprints.org (2025)
Gattani V, Dawre S. Development of favipiravir-loaded PLGA nanoparticles entrapped in in situ gel for treatment of COVID-19 via nasal route. J. Drug Deliv. Sci. Technol., 79, 104082 (2023) https://doi.org/10.1016/j.jddst.2022.104082
Jabir SA, Rajab N. Preparation, in vitro, ex vivo, and pharmacokinetic study of lasmiditan as intranasal nano-emulsion-based in situ gel. Pharm. Nanotechnol., 13, 239–253 (2024) https://doi.org/10.2174/0122117385285009231222072303
Published
How to Cite
Issue
Section
Copyright (c) 2026 Mansi Butola, Vikash Jakhmola
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
